Back to top
more

HealthEquity (HQY)

(Delayed Data from NSDQ)

$79.56 USD

79.56
736,794

+2.47 (3.20%)

Updated Aug 30, 2024 04:00 PM ET

After-Market: $79.51 -0.05 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (172 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Intuitive Surgical (ISRG) Q4 Earnings Top, Margins Expand

Intuitive Surgical (ISRG) gains from solid international show in Q4.

NextGen (NXGN) Earnings and Revenues Beat Estimates in Q3

NextGen (NXGN) gains from Recurring revenues in Q3, bookings down.

Sapna Bagaria headshot

Teladoc (TDOC) Hits 52-Week High: Will Momentum Sustain?

Teladoc (TDOC) stock gains from from positive earnings pre-announcement and news to acquire InTouch Health.

Here's Why You Should Add DexCom (DXCM) to Your Portfolio

DexCom (DXCM) expects its strong product portfolio to consistently drive top line.

Nevro (NVRO) Gains Ground on Solid Preliminary Q4 Results

Higher revenues and upbeat 2020 worldwide revenue outlook benefit Nevro's (NVRO) preliminary Q4 results.

Allscripts Expands Partnership With PIH Health Through 2025

Encouraged by its solid EHR prospects, Allscripts (MDRX) expects a surge in its fourth-quarter 2019 bookings.

Inogen (INGN) Announces Preliminary Q4 Results, Slashes View

Inogen (INGN) expects direct-to-consumer sales to be its fastest-growing channel in 2020.

ABIOMED (ABMD) Announces Preliminary Q3 Results, Slashes View

ABIOMED's (ABMD) Q3 international revenues grew year over year; fiscal 2020 view slashed.

Teladoc to Buy InTouch Health, Expand Reach in Virtual Care

Teladoc (TDOC) to acquire InTouch Health and provide virtual health solutions ranging from critical to everyday care.

Here's Why You Should Add Cerner (CERN) to Your Portfolio

Cerner (CERN) expects revenues between $1.41 billion and $1.46 billion in the fourth quarter.

Here's Why You Should Hold on to AngioDynamics Stock Now

AngioDynamics (ANGO) retains fiscal 2020 view; VA revenues soft in fiscal Q2.

Walgreens Boots (WBA) Q1 Earnings Lag Estimates, Margins Fall

Sluggishness in Walgreens Boots' (WBA) Retail Pharmacy International segment and margin contractions put pressure on the bottom line during Q1.

AngioDynamics (ANGO) Q2 Earnings Top, Revenues Lag Estimates

AngioDynamics (ANGO) gains from core Oncology business in the fiscal second quarter, reiterates guidance.

Walgreens Boots (WBA) to Post Q1 Earnings: What's in Store?

Higher comparable pharmacy sales and expanded comparable prescription volume are likely to have aided growth in Walgreens Boots' (WBA) Retail Pharmacy USA during the first quarter of fiscal 2020.

Here's Why You Should Hold on to Becton, Dickinson Stock Now

Becton, Dickinson (BDX) expects fiscal 2020 revenue growth to be driven by recent product launches.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for December 30th

Here are 4 stocks added to the Zacks Rank #1 (Strong Buy) List for today:

Top Ranked Momentum Stocks to Buy for December 30th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 30th

ERFSF or HQY: Which Is the Better Value Stock Right Now?

ERFSF vs. HQY: Which Stock Is the Better Value Option?

HMS Holdings Acquires Nebraska-Based Intrado's Accent Unit

The latest deal is likely to boost HMS Holdings' (HMSY) Payment Integrity solutions business.

Here's Why You Should Hold on to Masimo (MASI) Stock Now

Masimo (MASI) raises revenue and earnings guidance for 2019.

Shivangi Deora headshot

Why HealthEquity (HQY) Could Be an Impressive Growth Stock

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).

Is HealthEquity (HQY) Stock Outpacing Its Medical Peers This Year?

Is (HQY) Outperforming Other Medical Stocks This Year?

Masimo (MASI) Expands Partnership with Texas-Based Drager

Masimo (MASI) sees a slew of developments in recent times.

Urmimala Biswas headshot

Hill-Rom (HRC) Rides on International Growth, New Launches

Hill-Rom (HRC) launches RetinaVue 700 Imager, EarlySense and WatchCare in 2019.

LHC Group Expands Partnership With Ochsner Health System

LHC Group (LHCG) sees major expansion in partnerships of late.